Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,036 Brain Cancer
clinical trials

Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Oakland, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Tacoma, WA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Tucson, AZ
Click here to add this to my saved trials
Low Grade Glioma Clinical Trial
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
Status: Enrolling, Phase III
Updated: 3/23/2018
mi
from
Madison, WI
Click here to add this to my saved trials
Low Grade Glioma Clinical Trial
A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma
Status: Enrolling, Phase III
Updated: 3/23/2018
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Norfolk, VA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Hershey, PA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Louisville, KY
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Orlando, FL
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase II
Updated: 2/13/2018
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hampton, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
VX-970 and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
Status: Enrolling, Phase I
Updated: 4/17/2018
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer
Status: Enrolling, Phase I
Updated: 6/21/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tacoma, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Torrance, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling, Phase II
Updated: 11/24/2015
mi
from
Stanford, CA
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling, Phase II
Updated: 11/24/2015
mi
from
Durham, NC
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Status: Enrolling, Phase II
Updated: 11/24/2015
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
A Study of High Risk Induction Chemotherapy for Neuroblastoma Without Prophylactic Administration of Myeloid Growth Factors
Status: Enrolling
Updated: 2/19/2018
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Status: Enrolling, Phase II
Updated: 2/28/2018
mi
from
New York, NY
Click here to add this to my saved trials
Retinoblastoma Clinical Trial
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients
Status: Enrolling, Phase IV
Updated: 7/12/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jackson, MS
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Rochester, MN
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Temple, TX
Click here to add this to my saved trials
Brain Metastases From Non-small Cell Lung Cancer (NSCLC) Clinical Trial
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
American Fork, UT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ames, IA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anaheim, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Avon, IN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bellingham, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Belpre, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Berkeley, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Berlin, VT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Billings, MT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Billings, MT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bismarck, ND
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boulder, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burnsville, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clinton, NC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clive, IA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cody, WY
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
1 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 100